Pay in 4 interest-free payments of $5.37 Learn more
Ships within 48 hours · Estimated delivery Oct 12 - Oct 17
Like GLP-1 rival Eli Lilly, which produces tirzepatide sold as Mounjaro for diabetes and Zepbound for weight loss Novo has struggled to meet booming demand for the revolutionary drugs, which are beginning to show promise in a range of other areas too, including sleep apnea, heart problems, kidney disease and Parkinsons
The primary antibodies (Supplemental File 2 Table 2) were diluted in block, added to the membranes, and incubated overnight at 4 C
As production struggles to keep up, the pharma industry is now focusing on the upcoming patent expiry of key GLP-1 drugs like semaglutide, expected to start in early 2026 in countries like India, Brazil, China, and Canada (some reports even suggest 2025)
GLP-1 injections like semaglutide and tirzepatide are powerful tools, but the real difference lies in how theyre managed
Oakley AJ, Lo Bello M, Battistoni A, Ricci G, Rossjohn J, Villar HO et al
US$ 26.80
US$ 20.51
US$ 27.22
US$ 28.44
